Distribution and Characteristics of Meibomian Gland Dysfunction Subtypes: A Multicenter Study in South Korea

다국어 초록 (Multilingual Abstract)

Purpose: We sought to evaluate the distribution and characteristics of meibomian gland dysfunction (MGD)and the treatment patterns for symptomatic MGD patients in South Korea.
Methods: One hundred ninety-six right eyes of 196 MGD patients were enrolled. For each patient, meibumexpressibility in the central eight glands in both the upper and lower eyelids was examined. Each upperand lower eyelid was separately classified into one of the following three subtypes: nonobvious obstructive(low-delivery without lid margin abnormality), obvious obstructive (low-delivery with lid margin abnormality),and hypersecretory (high-delivery with lid margin abnormality). All treatment plans were also recorded.
Results: The mean number of expressible glands of the central eight glands in the upper eyelids (3.9 ± 2.6)was significantly higher than that in the lower eyelids (2.2 ± 2.4, p < 0.001). Obvious obstructive MGD wasthe most common subtype, followed by the hypersecretory and nonobvious obstructive subtypes in boththe upper and lower eyelids. Of the 196 subjects, 38 (19.4%) had upper and lower eyelids that were assignedto different categories. Eyelid hygiene was the most prescribed treatment (74.5%), followed by lubricant eyedrop usage (71.5%). Physicians tended to determine treatment plans based on the subtype of the upper eyelidrather than that of the lower eyelid.
Conclusions: The majority of subjects were classified as having the obvious obstructive subtype of MGD, and19.4% had upper and lower eyelids that were different subtypes. Eyelid hygiene was the most prescribedtreatment for MGD patients, and treatment patterns were mostly determined based on the subtype of theupper eyelids.

참고문헌 (Reference)

1 Kim HM, "The relationship between morphology and function of the meibomian glands" 44 : 1-5, 2018

2 Na KS, "The ocular benefits of estrogen replacement therapy : a population-based study in postmenopausal Korean women" 9 : e106473-, 2014

3 Nelson JD, "The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee" 52 : 1930-1937, 2011

4 Nichols KK, "The international workshop on meibomian gland dysfunction: executive summary" 52 : 1922-1929, 2011

5 "The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)" 5 : 75-92, 2007

6 Bron AJ, "The contribution of meibomian disease to dry eye" 2 : 149-165, 2004

7 Duke-Elder WS, "System of ophthalmology. Vol. XIII" H. Kimpton 241-, 1974

8 Lekhanont K, "Prevalence of dry eye in Bangkok, Thailand" 25 : 1162-1167, 2006

9 Viso E, "Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain" 53 : 2601-2606, 2012

10 Siak JJ, "Prevalence and risk factors of meibomian gland dysfunction : the Singapore Malay Eye Study" 31 : 1223-1228, 2012

11 Blackie CA, "Nonobvious obstructive meibomian gland dysfunction" 29 : 1333-1345, 2010

12 Kozak I, "Morphologic and volumetric studies of the meibomian glands in elderly human eyelids" 26 : 610-614, 2007

13 McCulley JP, "Meibomian keratoconjunctivitis" 84 : 788-793, 1977

14 Jester JV, "Meibomian gland studies : histologic and ultrastructural investigations" 20 : 537-547, 1981

15 Shimazaki J, "Meibomian gland dysfunction in patients with Sjogren syndrome" 105 : 1485-1488, 1998

16 Korb DR, "Meibomian gland dysfunction and contact lens intolerance" 51 : 243-251, 1980

17 Foulks GN, "Meibomian gland dysfunction : a clinical scheme for description, diagnosis, classification, and grading" 1 : 107-126, 2003

18 Driver PJ, "Meibomian gland dysfunction" 40 : 343-367, 1996

19 Goto E, "Low-concentration homogenized castor oil eye drops for noninflamed obstructive meibomian gland dysfunction" 109 : 2030-2035, 2002

20 Arita R, "Increased tear fluid production as a compensatory response to meibomian gland loss : a multicenter cross-sectional study" 122 : 925-933, 2015

21 Wan T, "Incomplete blinking may attribute to the development of meibomian gland dysfunction" 41 : 179-185, 2016

22 Seifert P, "Immunocytochemical and ultrastructural evaluation of the distribution of nervous tissue and neuropeptides in the meibomian gland" 234 : 648-656, 1996

23 Sirigu P, "Human meibomian glands : the ultrastructure of acinar cells as viewed by thin section and freeze-fracture transmission electron microscopies" 33 : 2284-2292, 1992

24 Bron AJ, "Grading of corneal and conjunctival staining in the context of other dry eye tests" 22 : 640-650, 2003

25 Craig JP, "Exploring the predisposition of the Asian eye to development of dry eye" 14 : 385-392, 2016

26 Amano S, "Estimation of prevalence of meibomian gland dysfunction in Japan" 36 : 684-688, 2017

27 Alghamdi YA, "Epidemiology of meibomian gland dysfunction in an elderly population" 35 : 731-735, 2016

28 Korb DR, "Effect of periocular humidity on the tear film lipid layer" 15 : 129-134, 1996

29 Eom Y, "Correlation between quantitative measurements of tear film lipid layer thickness and meibomian gland loss in patients with obstructive meibomian gland dysfunction and normal controls" 155 : 1104-1110, 2013

30 Eom Y, "Comparison of meibomian gland loss and expressed meibum grade between the upper and lower eyelids in patients with obstructive meibomian gland dysfunction" 33 : 448-452, 2014

31 Eom Y, "Comparison of conjunctival staining between lissamine green and yellow filtered fluorescein sodium" 50 : 273-277, 2015

32 Amano S, "Clinic-based study on meibomian gland dysfunction in Japan" 58 : 1283-1287, 2017

33 Lin PY, "Association between symptoms and signs of dry eye among an elderly Chinese population in Taiwan : the Shihpai Eye Study" 46 : 1593-1598, 2005

34 Song JY, "Association between menstrual irregularity and dry eye disease : a population-based study" 35 : 193-198, 2016

35 Sullivan DA, "Androgen deficiency, meibomian gland dysfunction and evaporative dry eye" 966 : 211-222, 2002

36 Dougherty JM, "Analysis of the free fatty acid component of meibomian secretions in chronic blepharitis" 27 : 52-56, 1986

37 Jung JW, "Analysis of factors associated with the tear film lipid layer thickness in normal eyes and patients with dry eye syndrome" 57 : 4076-4083, 2016

38 Lemp MA, "Advances in understanding and managing dry eye disease" 146 : 350-356, 2008